editor
paul
healthcar
personnel
igg
incid
middl
east
respiratori
syndrom
person
protect
equip
b
r
c
given
mode
transmiss
middl
east
respiratori
syndrom
mer
healthcar
worker
hcw
contact
mer
patient
expect
risk
mer
infect
evalu
preval
mer
coronaviru
cov
immunoglobulin
ig
g
hcw
expos
mer
patient
calcul
incid
mersaffect
case
hcw
enrol
hcw
hospit
confirm
mer
patient
visit
serum
collect
week
last
contact
confirm
mer
patient
perform
enzymelink
immunosorb
assay
elisa
screen
presenc
merscov
igg
indirect
immunofluoresc
test
iift
confirm
merscov
igg
use
questionnair
collect
inform
regard
exposur
calcul
incid
mersaffect
case
divid
sum
pcrconfirm
serologyconfirm
case
number
expos
hcw
particip
hospit
total
hcw
hospit
contact
mer
patient
among
hcw
pcrconfirm
mer
case
studi
hospit
serolog
analysi
perform
particip
elisa
posit
five
particip
borderlin
seven
iift
posit
two
particip
among
particip
use
appropri
person
protect
equip
ppe
seroposit
compar
case
appropri
ppe
use
incid
mer
infect
hcw
seropreval
merscov
igg
among
hcw
higher
among
particip
use
appropri
ppe
cj
kim
cmi
middl
east
respiratori
syndrom
mer
emerg
infecti
diseas
first
describ
saudi
arabia
mainli
found
within
middl
eastern
region
case
report
outsid
middl
east
epidem
event
outsid
middl
east
seen
howev
year
largest
singlen
outbreak
outsid
saudi
arabia
occur
south
korea
day
confirm
mer
patient
includ
death
http
wwwmersgokrmershtml
main
mode
transmiss
mer
respiratori
droplet
mer
transmiss
occur
nosocomi
set
healthcar
worker
hcw
contact
confirm
mer
patient
high
risk
mer
infect
south
korea
among
laboratoryconfirm
mer
patient
case
occur
medic
profession
hcw
spectrum
clinic
manifest
mer
divers
patient
includ
number
affect
hcw
show
rel
mild
symptom
therefor
suspect
asymptomat
undetect
mer
infect
may
present
hcw
involv
manag
confirm
mer
patient
one
previou
studi
report
mer
coronaviru
cov
pcrposit
patient
asymptomat
among
hcw
moreov
period
merscov
present
respiratori
specimen
unknown
viru
shed
mechan
still
ambigu
even
confirm
mer
patient
pcr
posit
rate
asymptomat
patient
remain
unknown
therefor
aim
evalu
seropreval
merscov
igg
hcw
expos
mer
patient
calcul
incid
mer
affect
case
hcw
furthermor
aim
identifi
risk
factor
mer
infect
hcw
enrol
hcw
particip
hospit
confirm
mer
patient
visit
treat
particip
hcw
includ
doctor
nurs
nurs
assist
radiolog
technologist
patient
transport
patient
caregiv
other
also
includ
studi
direct
contact
confirm
mer
patient
studi
use
mandatori
surveil
agre
particip
studi
enrol
hcw
alreadi
diagnos
pcrconfirm
mer
includ
serolog
assay
includ
calcul
incid
includ
particip
individu
direct
contact
confirm
mer
patient
direct
contact
defin
follow
share
convers
confirm
mer
patient
within
reach
b
stay
patient
close
room
longer
minut
c
direct
contact
respiratori
gastrointestin
secret
patient
environment
factor
air
circul
condit
consid
vari
markedli
among
hospit
studi
hospit
divid
two
group
mersreferr
hospit
pcrconfirm
mer
patient
refer
manag
wherea
mersaffect
hospit
patient
suspect
mer
visit
confirm
diagnosi
patient
fever
respiratori
symptom
visit
mersaffect
rather
mersreferr
hospit
mer
confirm
mean
merscov
pcr
patient
transfer
design
mersreferr
hospit
hospit
initi
visit
patient
suspect
patient
admit
manag
laboratori
confirm
mer
hospit
serv
singl
stop
patient
defin
mersaffect
studi
particip
hcw
quarantin
contact
surveil
contact
confirm
mer
patient
decis
quarantin
contact
surveil
made
nation
epidem
intellig
servic
offic
dispatch
specif
hospit
accord
nation
guidelin
brief
hcw
close
contact
mer
patient
without
appropri
protect
patient
place
quarantin
casual
contact
occur
patient
place
contact
surveil
hcw
quarantin
confin
home
quarantin
facil
day
respiratori
symptom
fever
develop
quarantin
hcw
merscov
pcr
respiratori
specimen
perform
twice
period
accord
nation
guidelin
institut
hcw
place
contact
surveil
monitor
daili
fever
respiratori
symptom
day
prohibit
work
hospit
definit
appropri
person
protect
equip
ppe
drawn
previou
recommend
http
www
appropri
ppe
defin
use
follow
respir
power
airpurifi
respir
papr
b
isol
gown
coveral
c
goggl
face
shield
glove
part
ppe
miss
consid
exposur
without
appropri
ppe
defin
aerosolgener
procedur
agp
follow
suction
airway
applic
highflow
instrument
bronchoscopi
intub
andor
cardiopulmonari
resuscit
case
agp
perform
papr
respir
consid
appropri
ppe
collect
serum
particip
identifi
presenc
merscov
igg
use
questionnair
survey
gather
inform
regard
hcw
demograph
characterist
extent
exposur
survey
questionnair
base
world
health
organ
questionnair
http
wwwwhointcsrdiseas
coronavirusinfectionshealthcaremersseroepiinvestig
serum
collect
week
last
contact
confirm
mer
patient
perform
enzymelink
immunosorb
assay
elisa
euroimmun
germani
screen
presenc
merscov
igg
case
optic
densiti
elisa
exceed
predefin
cutoff
valu
refer
valu
perform
indirect
immunofluoresc
test
iift
euroimmun
confirm
merscov
igg
quantifi
antibodi
titr
cutoff
elisa
valu
refer
valu
posit
borderlin
result
serum
dilut
accord
protocol
suggest
manufactur
antibodi
titr
measur
conduct
twofold
dilut
data
analys
spss
softwar
ibm
spss
chicago
il
usa
compar
mersreferr
mersaffect
hospit
use
chisquar
test
mannwhitney
u
test
test
two
side
p
valu
less
consid
signific
incid
calcul
follow
incid
mersinfect
case
number
pcrconfirm
mer
case
particip
hospit
number
serologyconfirm
mer
case
particip
hospit
total
number
mer
expos
hcw
particip
hospit
particip
enrol
onto
studi
voluntarili
written
inform
consent
acquir
particip
studi
protocol
approv
institut
review
board
ewha
woman
univers
mokdong
hospit
seoul
south
korea
eumc
trial
submit
clinicaltrialsgov
identifi
eighteen
mersaffect
hospit
mersreferr
hospit
particip
studi
fig
total
case
mer
manag
particip
hospit
total
hcw
contact
mer
patient
studi
hospit
mersaffect
hospit
mersreferr
hospit
among
diagnos
pcrconfirm
mer
quarantin
mersaffect
hospit
four
hundr
seventeen
hcw
agre
particip
studi
therefor
hcw
enrol
onto
studi
fig
particip
doctor
account
nurs
radiolog
technologist
tabl
mersaffect
hospit
particip
quarantin
wherea
particip
mersreferr
hospit
quarantin
baselin
characterist
particip
shown
tabl
elisa
result
posit
five
particip
borderlin
seven
particip
iift
posit
two
among
particip
show
borderlin
posit
result
elisa
total
tabl
quantit
iift
show
titr
antibodi
respect
found
two
seroposit
case
among
particip
therefor
seropreval
merscov
igg
among
hcw
expos
mer
patient
asymptomat
symptomat
neg
merscov
pcr
basi
case
pcrconfirm
mer
case
studi
hospit
assum
least
hcw
affect
mer
incid
least
five
case
men
women
overal
particip
report
one
symptom
within
week
contact
pcrconfirm
mer
patient
gener
symptom
includ
fever
fatigu
myalgia
frequent
report
respiratori
symptom
report
gastrointestin
symptom
particip
total
durat
contact
mer
patient
mean
durat
contact
mer
patient
day
significantli
longer
mersreferr
hospit
two
hundr
ninetyfour
particip
expos
one
pcrconfirm
mer
patient
without
least
one
form
appropri
ppe
exposur
agp
without
papr
occur
particip
tabl
among
particip
even
one
occas
use
appropri
ppe
seroposit
compar
among
use
appropri
everi
time
among
particip
expos
agp
seroposit
among
expos
without
papr
even
wherea
seroposit
among
expos
papr
tabl
studi
evalu
seropreval
merscov
among
hcw
contact
mer
patient
found
two
asymptomat
subclin
mer
infect
hcw
expos
without
appropri
ppe
overal
preval
merscov
seroposit
among
particip
use
appropri
ppe
seroposit
consid
pcrconfirm
mer
case
among
hcw
studi
hospit
incid
mer
affect
case
among
expos
hcw
least
merscov
seropreval
among
popul
confirm
mer
patient
limit
recent
report
seropreval
merscov
igg
among
gener
popul
saudi
arabia
highrisk
popul
suggest
number
case
asymptomat
mild
infect
may
present
highrisk
popul
howev
suffici
merscov
igg
seropreval
data
among
hcw
compar
result
mer
middl
east
respiratori
syndrom
one
particip
doctor
orient
medicin
exclud
depart
classif
b
particip
expos
multipl
site
sever
acut
respiratori
syndromeeaffect
area
seropreval
among
hcw
use
confirmatori
test
rang
suggest
undetect
asymptomat
case
present
epidem
studi
found
similar
proport
mer
subclin
infect
among
hcw
prevent
mer
infect
hcw
use
ppe
emphas
gener
isol
gown
glove
recommend
contact
precaut
surgic
mask
recommend
droplet
precaut
although
mer
known
transmit
droplet
direct
contact
use
appropri
ppe
includ
respir
isol
gown
emphas
prevent
mer
infect
http
wwwcdcgovcoronavirusm
studi
particip
expos
mer
patient
without
appropri
ppe
igg
antibodi
merscov
also
found
pcrconfirm
mersinfect
hcw
among
pcrconfirm
mersinfect
hcw
http
wwwmersgokr
review
patient
affili
studi
particip
hospit
data
shown
found
patient
expos
without
use
respir
therefor
particip
hospit
almost
mersinfect
hcw
relat
use
appropri
ppe
two
except
case
use
isol
gown
respir
follow
us
center
diseas
control
prevent
guidelin
http
wwwcdcgov
eventu
infect
mer
expos
agp
intub
mer
patient
seroposit
case
studi
cardiopulmonari
resuscit
mer
patient
pcrconfirm
mer
case
although
fit
test
perform
either
case
guess
respir
less
effici
agp
highvirusburden
patient
consequ
appropri
use
ppe
import
protect
mer
perform
agp
effici
respir
might
necessari
previou
studi
presenc
merscov
igg
confirm
neutral
assay
plaqu
reduct
neutral
test
microneutr
assay
et
al
report
sampl
receiv
posit
elisa
result
antibodi
antigen
posit
neutral
assay
studi
howev
iift
well
correl
neutral
assay
report
show
elisa
alon
use
screen
presenc
merscov
igg
confirm
wherea
iift
could
substitut
neutral
assay
anoth
recent
report
correl
merscov
elisa
neutral
assay
strong
pcrconfirm
mer
patient
therefor
protocol
compos
screen
merscov
elisa
confirm
iift
may
robust
detect
truli
seroposit
sampl
studi
sever
limit
firstli
optim
time
serum
collect
mer
test
unknown
unknown
long
serum
antibodi
persist
mersinfect
patient
moreov
recent
studi
shown
confirm
mer
patient
mild
symptom
borderlin
serum
igg
level
day
diagnosi
thu
neg
elisa
result
particip
may
fals
neg
secondli
work
research
purpos
particip
mandatori
voluntari
therefor
hcw
expos
mer
patient
enrol
approxim
hospit
clinic
south
korea
affect
mer
hospit
design
mersreferr
hospit
among
institut
hospit
particip
studi
hospit
hcw
mersaffect
hospit
mersreferr
hospit
particip
institut
potenti
expos
confirm
mer
patient
particip
thirdli
estim
incid
mersaffect
hcw
could
underestim
two
reason
firstli
hcw
agre
enrol
onto
studi
seroposit
case
may
miss
secondli
two
hospit
larg
cluster
case
develop
particip
studi
incid
mersaffect
case
hospit
may
higher
other
hospit
includ
one
visit
first
korean
mersinfect
patient
anoth
largest
superspread
event
occur
hospit
hcw
prepar
high
risk
infect
appropri
ppe
use
manag
patient
earli
period
outbreak
therefor
seropreval
would
expect
higher
hospit
other
conclus
seropreval
merscov
igg
hcw
contact
mer
patient
particip
hospit
found
among
particip
use
appropri
ppe
calcul
incid
mersaffect
case
hcw
least
seropreval
merscov
igg
higher
among
particip
use
appropri
ppe
work
support
research
program
fund
korea
center
diseas
control
prevent
author
report
conflict
interest
relev
articl
